These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8785072)

  • 1. Screening and the new genetics; a public health perspective on the ethical debate.
    Stone DH; Stewart S
    J Public Health Med; 1996 Mar; 18(1):3-5. PubMed ID: 8785072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and the new genetics.
    Cooper JD; Franks AJ
    J Public Health Med; 1997 Mar; 19(1):121. PubMed ID: 9138228
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient and parental attitudes toward genetic screening and its implications at an adult cystic fibrosis centre.
    Conway SP; Allenby K; Pond MN
    Clin Genet; 1994 Jun; 45(6):308-12. PubMed ID: 7923862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
    Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
    Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group.
    Axworthy D; Brock DJ; Bobrow M; Marteau TM
    Lancet; 1996 May; 347(9013):1443-6. PubMed ID: 8676627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening.
    Modra LJ; Massie RJ; Delatycki MB
    Med J Aust; 2010 Aug; 193(3):157-60. PubMed ID: 20678044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal privacy and confidentiality.
    Botkin JR
    Hastings Cent Rep; 1995; 25(5):32-9. PubMed ID: 8530268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cystic fibrosis.
    Dodge JA; Ryley HC
    Arch Dis Child; 1982 Oct; 57(10):774-80. PubMed ID: 7138066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct marketing of cystic fibrosis carrier screening: commercial push or population need?
    Cuckle H; Lilford R; Wilson J; Sehmi I
    J Med Genet; 1995 Sep; 32(9):758. PubMed ID: 8544204
    [No Abstract]   [Full Text] [Related]  

  • 10. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic screening: marvel or menace?
    Rowley PT
    Science; 1984 Jul; 225(4658):138-44. PubMed ID: 6729472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for carriers of cystic fibrosis--a general practitioner's perspective.
    Modell M
    BMJ; 1993 Oct; 307(6908):849-52. PubMed ID: 8401130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of the new genetics for screening for cystic fibrosis.
    Dodge JA
    Lancet; 1988 Sep; 2(8612):672-4. PubMed ID: 2901527
    [No Abstract]   [Full Text] [Related]  

  • 14. Whole-population screening for carriers of cystic fibrosis gene.
    Carswell F
    Lancet; 1996 May; 347(9013):1421-2. PubMed ID: 8676620
    [No Abstract]   [Full Text] [Related]  

  • 15. Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling.
    Mischler EH; Wilfond BS; Fost N; Laxova A; Reiser C; Sauer CM; Makholm LM; Shen G; Feenan L; McCarthy C; Farrell PM
    Pediatrics; 1998 Jul; 102(1 Pt 1):44-52. PubMed ID: 9651412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of antenatal screening for cystic fibrosis.
    Cuckle HS; Richardson GA; Sheldon TA; Quirke P
    BMJ; 1995 Dec; 311(7018):1460-3; discussion 1463-4. PubMed ID: 8520332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of population based screening for carriers of cystic fibrosis.
    Bekker H; Denniss G; Modell M; Bobrow M; Marteau T
    J Med Genet; 1994 May; 31(5):364-8. PubMed ID: 8064812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ethics of cystic fibrosis carrier screening: where do we stand?
    De Braekeleer M; Mélançon MJ
    Am J Hum Genet; 1990 Sep; 47(3):580-1. PubMed ID: 2393029
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic advances in cystic fibrosis: to screen, to treat or both?
    Super M; Abbott J
    Disabil Rehabil; 1998; 20(6-7):202-8. PubMed ID: 9637928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.